USPTO serial 79353205
ADPS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 13, 2024
- Examiner
- HARMON, RAYMOND E
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with ADPS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
MAX VERN
MAX VERN AMSTER, ROTHSTEIN & EBENSTEIN LLP405 LEXINGTON AVENUENEW YORK, NY 10174UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations and substances for the prevention of cancer; biopharmaceuticals for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; diagnostic agents for pharmaceutical use; diagnostic preparations for medical purposes; medical diagnostic test strips for blood analysis; diagnostic reagents for use in diagnostic tests for medical purposes; medical diagnostic reagents; chemical diagnostic reagents for medical use; in vitro diagnostic preparations for medical purposes for detecting cancer; indicators for medical diagnosis, namely, medical diagnostic reagents; reactants for medical diagnosis, namely, medical diagnostic reagents; pharmaceutical preparations for animals and humans for the treatment of cancer; pharmaceutical preparations for diagnosis of cancer; anti-cancer preparations | ACTIVE | — |
| 010 | Apparatus for the treatment of cancer; medical measuring instruments for measuring tumors for cancer diagnosis; medical instruments, namely, biopsy instruments; medical apparatus for detecting cancer; diagnostic measuring apparatus for medical use, namely, medical diagnostic apparatus for analyzing and measuring tumors in the body; apparatus for carrying-out diagnostic tests for testing for cancers for medical purposes; diagnostic apparatus for medical purposes for testing cancers; apparatus for blood analysis for medical use; apparatus for blood monitoring for medical use; medical diagnostic apparatus for detecting cancer for use in the fields of clinical diagnosis; diagnostic, examination, and monitoring equipment in the nature of medical diagnostic apparatus for detecting cancer; testing instruments for medical diagnostic purposes, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; automatic analyzers for medical diagnosis for analyzing circulating tumor DNA; tools for medical diagnostics in the nature of medical diagnostic apparatus for detecting cancer; medical examination sheets in the nature of medical table sheets for examining tables and operating tables; apparatus for clinical diagnosis; diagnostic apparatus and instruments for medical purposes in the nature of medical diagnostic apparatus for detecting cancer; blood analysis apparatus for medical diagnosis purposes; in vitro diagnostic devices for medical purposes in the nature of medical diagnostic apparatus for detecting cancer | ACTIVE | — |
| 035 | Wholesale store services featuring medical measuring instruments for cancer diagnosis; retail store services featuring medical measuring instruments for cancer diagnosis; wholesale store services featuring medical instruments; retail store services featuring medical instruments; retail store services featuring diagnostic reagents for medicinal use; retail store services featuring medical diagnostic test strips; wholesale store services featuring medical diagnostic test strips; retail store services featuring reagents for use in diagnostic tests for medical purposes; wholesale store services featuring reagents for use in diagnostic tests for medical purposes; wholesale store services featuring diagnostic reagents for medicinal use; retail store services featuring testing instruments for medical diagnostic purposes; wholesale store services featuring testing instruments for medical diagnostic purposes; wholesale store services featuring pharmaceuticals; retail store services featuring pharmaceuticals; wholesale store services featuring pharmaceutical preparations for animals and humans; retail store services featuring pharmaceutical preparations for animals and humans; retail store services featuring apparatus for clinical diagnosis; wholesale store services featuring apparatus for clinical diagnosis; wholesale store services featuring blood analysis apparatus for diagnosis; retail store services featuring blood analysis apparatus for diagnosis | ACTIVE | — |
| 042 | Research and development of technology for biotechnology; biotechnology services, namely, consulting services in the field of biotechnology; scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; development of pharmaceutical preparations and medicines; medical research laboratory services; medical research laboratory services for predicting disease; remote monitoring services for medical diagnostic devices; computer programming services for remote data management of medical diagnostic instruments; design of medical diagnostic apparatus and instruments; providing technological support services in the nature of troubleshooting in the nature of diagnosing problems with medical equipment regarding medical diagnostic instruments; providing computer software technical support services in the nature of diagnosing computer hardware and software problems in the field of medical diagnostics; computer programming services for remote control of medical diagnostic systems; engineering services in the medical technology field; blood testing for medical research purposes, not for medical diagnostic purposes; medical research; medical and scientific research, namely, conducting clinical trials for others; blood analysis services; blood analysis services for scientific research purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by GeneCast Co., Ltd.
- Other trademarks owned by GeneCast Co., Ltd.
- Other trademarks owned by GeneCast Co., Ltd.
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 035
- Other trademarks in Class 042
- Similar marks named ADPS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 22, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 1, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 1, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 13, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 13, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Aug 13, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 5, 2024 | TMBN | TTAB RELEASE CASE TO TRADEMARKS | — |
| Jul 5, 2024 | OP.T | OPPOSITION TERMINATED NO. 999999 | — |
| Jul 5, 2024 | OP.D | OPPOSITION DISMISSED NO. 999999 | — |
| Apr 23, 2024 | RFNP | REFUSAL PROCESSED BY IB | — |
| Apr 8, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Mar 27, 2024 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Mar 27, 2024 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| Mar 26, 2024 | OPNS | OPPOSITION NOTICE (IB REFUSAL) SENT TO IB | — |
| Mar 26, 2024 | OPNC | OPPOSITION NOTICE (IB REFUSAL) CREATED | — |
| Mar 20, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 20, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Oct 25, 2023 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Sep 26, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 26, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 25, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Sep 6, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 6, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Sep 6, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 21, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 21, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 21, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 18, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 17, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 17, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 7, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 14, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 14, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 9, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 8, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 1, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 25, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 21, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 20, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |